ImedEXTRA: Medical Information Update

May 16, 2008
Jean Sindab Triple-Negative Breast Cancer Symposium
Grand Hyatt Atlanta in Buckhead
Azalea Room
3300 Peachtree Road NE
Atlanta, Georgia, USA 30305
Tel: +1 404 237 1234
Fax: +1 404 233 5686
www.grandatlanta.hyatt.com
Atlanta, Georgia

Chair:
Ruth M. O'Regan, MD
Director, Translational Breast Cancer Research Program
Emory University
Winship Cancer Institute

Meeting Purpose:
The inaugural Jean Sindab Triple-Negative Breast Cancer Symposium is designed to update oncologists on the most current advances in triple-negative breast cancer.

Jean Sindab, PhD, was a Yale educated, African-American scholar and activist who died at 51 from breast cancer. Dr. Sindab's memory is honored at Emory Winship Cancer Institute through the Jean Sindab Endowment, which provides key funding for research in triple-negative breast cancer.

Symposium Support:
The Jean Sindab Triple-Negative Breast Cancer Symposium is made possible by a gift from Kathelen and Dan Amos in honor of Aflac's African American female managers and employees.

Continuing Medical Education:
Imedex^®, LLC is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Imedex, LLC designates this educational activity for a maximum 7.5 of AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Who Should Attend:
This educational activity is designed for medical oncologists, radiation oncologists, surgical oncologists, radiologists, pathologists, and other healthcare providers involved or interested in the diagnosis, treatment, and management of breast cancer.

Objectives:
Upon completion of this activity, attendees should be able to:
• Discuss the epidemiologic aspects of triple-negative breast cancers
• Identify the relationship between hereditary breast cancer and triple-negative breast cancers
• Evaluate local therapeutic options for triple-negative breast cancers
• Describe systemic therapy options for triple-negative breast cancers
• Review current and emerging research in the pathogenesis and therapies for triple-negative
breast cancers

Conference Organizer:
Emory University
Winship Cancer Institute
1365C Clifton Road
Atlanta, Georgia 30322
http://cancer.emory.edu
404-778-5452

To Register
There is no cost to attend. The Jean Sindab Triple-Negative Breast Cancer Symposium is made possible by a gift from Kathelen and Dan Amos in honor of Aflac's African American female managers and employees.

You may register online at www.cancer.emory.edu/SindabSymposium
or by telephone at 404-778-5452.

Scientific Agenda

8:00-8:35	Basal-like breast cancer: a distinct biologic entity? Lisa A. Carey, MD
8:35-9:10	Update on radiation therapy in breast cancer Lori J. Pierce, MD
9:10-9:45	Surgical issues in triple-negative cancers Lisa A. Newman, MD, MPH, FACS
9:45-10:20	BREAK
10:20-10:55	Pathology of triple-negative cancers W. Fraser Symmans, MD
10:55-11:30	Screening for triple-negative cancers Robert A. Smith, PhD
11:30-12:30	Inaugural Jean Sindab Lecture: Breast cancer - from cells to society Olufunmilayo Falusi Olopade, MD, MBBS, FACP
12:30-1:15	LUNCH
1:15-1:40	The p53 pathway and adriamycin resistance in triple-negative breast cancer cells Harold I. Saavedra, PhD
1:40-2:05	Clinical and research successes in the AVON Comprehensive Breast Center at Grady Memorial Hospital Sheryl G.A. Gabram-Mendola, MD, MBA
2:05-2:30	Using epigenetics to sensitize triple-negative breast cancer cells to endocrine therapy Dipali Sharma, PhD and Paula M. Vertino, PhD
2:30-2:55	Epidemiology and pathology of triple-negative cancers in Atlanta Mary Jo Lund, PhD
2:55-3:05	BREAK
3:05-3:30	Cellular origin and mechanisms of aggressive tumor biology for triple-negative breast cancer Lily Yang, MD, PhD
3:30-3:55	Genomics of triple-negative cancers Brian Leyland-Jones, MD, PhD
3:55-4:20	Neoadjuvant chemotherapy for ER-, PR-, HER2- (triple-negative) breast cancer Amelia B. Zelnak, MD and Toncred M. Styblo, MD
4:20-4:45	Surgical issues with triple-negative cancers at Georgia Cancer Center of Excellence at Grady Monica Rizzo, MD and Harvey L. Bumpers, MD
4:45-5:10	Higher recurrence rates after breast conserving therapy Sandra Shaker Zaky
5:10-5:25	Closing remarks Ruth O'Regan, MD
	To Register: www.cancer.emory.edu/SindabSymposium Imedex and Emory Winship Cancer Institute do not accept responsibility for covering travel, accommodation, or any other costs incurred by registrants in the rare event that this meeting should be canceled for any reason. Every effort will be made to give reasonable notice in the event of cancellation. The event agenda is subject to change without notice.

Faculty
Harvey L. Bumpers, MD Professor of Surgery, Director of Surgical Oncology and Breast Services Morehouse School of Medicine Atlanta, Georgia Lisa A. Carey, MD Medical Director, UNC Breast Center Lineberger Cancer Center University of North Carolina Chapel Hill, North Carolina Sheryl G.A. Gabram-Mendola, MD, MBA Professor of Surgery, Director AVON Comprehensive Breast Center at Grady Memorial Hospital Emory University Winship Cancer Institute Atlanta, Georgia Brian Leyland-Jones, MD, PhD Associate Vice President and Director Emory University Winship Cancer Institute Atlanta, Georgia Mary Jo Lund, PhD Assistant Professor Emory University Rollins School of Public Health Atlanta, Georgia Lisa A. Newman, MD, MPH, FACS Medical Director, Breast Care Center Associate Professor, Surgery University of Michigan Comprehensive Cancer Center Ann Arbor, Michigan	Olufunmilayo Falusi Olopade, MD, MBBS, FACP Professor, Department of Medicine Director, Center for Clinical Cancer Genetics University of Chicago Medical Center Chicago, Illinois Ruth O'Regan, MD Director, Translational Breast Cancer Research Program Emory University Winship Cancer Institute Atlanta, Georgia Lori J. Pierce, MD Vice Provost for Academic & Faculty Affairs Professor–Department of Radiation Oncology University of Michigan Ann Arbor, Michigan Monica Rizzo, MD Director, Emory Breast Clinic at Grady Memorial Hospital Assistant Professor in Surgery Emory University Winship Cancer Institute Atlanta, Georgia Harold I. Saavedra, PhD Assistant Professor Emory University Winship Cancer Institute Atlanta, Georgia Dipali Sharma, PhD Assistant Professor Hematology and Medical Oncology Emory University Winship Cancer Institute Atlanta, Georgia	Robert A. Smith, PhD Director of Cancer Screening American Cancer Society Atlanta, Georgia Toncred M. Styblo, MD Associate Professor of Surgery Emory University School of Medicine Atlanta, Georgia W. Fraser Symmans, MD Associate Professor of Pathology University of Texas - M. D. Anderson Cancer Center Houston, Texas Paula M. Vertino, PhD Associate Professor Department of Radiation Oncology Emory University Winship Cancer Institute Atlanta, Georgia Lily Yang, MD, PhD Associate Professor of Surgery and Radiology Emory University Winship Cancer Institute Atlanta, Georgia Amelia B. Zelnak, MD Instructor of Hematology and Oncology Emory University Winship Cancer Institute Atlanta, Georgia

4325 Alexander Drive, Alpharetta, GA 30022-3740 USA
Tel.: +1 (770) 751 7332 | Fax:+1 (770) 751 7334 | meetings@imedex.com | www.imedex.com